SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?


To: Sam Citron who wrote (1683)2/24/2000 1:23:00 PM
From: MGV  Read Replies (2) | Respond to of 1754
 
No, my take from the sentence below is that B&L has chosen for the moment to draw a line in the sand.

"In light of current patent litigation pending against doctors performing LASIK using certain competitive lasers, the company will indemnify its customers for costs associated with any third-party patent infringement lawsuit, if that becomes necessary."

Now the PTO reissue decision on the Trokel '388 is a little more significant.

The market hasn't absorbed the release the way I have as VISX is up to highs for the day now - 19 as I post.



To: Sam Citron who wrote (1683)2/24/2000 1:29:00 PM
From: Charlie Smith  Read Replies (2) | Respond to of 1754
 
Sam:

Seems as if it does. $100 is now the number and deep pockets wins. How long does $100 equilibrium last?

VISX is the pure, riskier way to play what should be raucous LVC procedure growth. BOL has the size to crush everybody if they want to, though. Will they?

Charlie